Group 1 - The total trade volume between China and North Korea in 2025 increased by 26% year-on-year, reaching $2.73487 billion, recovering to levels similar to those before the COVID-19 pandemic in 2019 [2][4] - In 2025, China's exports to North Korea grew by 25% year-on-year, amounting to $2.29469 billion, while imports from North Korea increased by 27%, totaling $440.18 million [4] - The growth in exports from China to North Korea was particularly notable in medical-related products, coinciding with the completion of several large hospitals in Pyongyang, which are considered key projects [4][5] Group 2 - In 2025, every month saw a year-on-year increase in trade between China and North Korea, contrasting sharply with 2024, where 11 out of 12 months experienced negative growth [4] - The rapid improvement in China-North Korea relations in 2025 is marked by a significant increase in trade, reversing the cooling trend observed in 2024 due to North Korea's deepening military cooperation with Russia [2]

Group 1 - The core viewpoint of the article is that the company, Weigao Medical, is actively monitoring global public health trends and is adjusting its production capacity and supply chain to ensure stable supply of related products [1] Group 2 - The company emphasizes its commitment to maintaining a stable supply of medical products in response to public health dynamics [1] - The company engages with investors through interactive platforms to address inquiries regarding its operations and strategies [1]